SU 4981

CAS No. 186610-88-8

SU 4981( 3-(4-Morpholinobenzylidene)indolin-2-one )

Catalog No. M28540 CAS No. 186610-88-8

SU 4981 is an inhibitor of VEGFR and a modulator of tyrosine kinase activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 393 Get Quote
10MG 581 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG 1674 Get Quote
500MG 3348 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SU 4981
  • Note
    Research use only, not for human use.
  • Brief Description
    SU 4981 is an inhibitor of VEGFR and a modulator of tyrosine kinase activity.
  • Description
    SU 4981 is an inhibitor of VEGFR and a modulator of tyrosine kinase activity.
  • In Vitro
    hVEGF-IN-2 (0-100 μM) shows the inhibitory activities to particular RTKs at the cellular level with IC50 values of 2.5, 33.1, >100, >100 and >100 nM for VEGF, PDGF, EGF, HER-2 and IGF-1, respectively.
  • In Vivo
    ——
  • Synonyms
    3-(4-Morpholinobenzylidene)indolin-2-one
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    Antioxidant|VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    186610-88-8
  • Formula Weight
    306.36
  • Molecular Formula
    C19H18N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1NC=2C=CC=CC2C1=CC3=CC=C(C=C3)N4CCOCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Afifi FU, Aburjai T. Antiplatelet activity of Varthemia iphionoides. Fitoterapia. 2004 Dec;75(7-8):629-33.
molnova catalog
related products
  • TG 100572 Hydrochlor...

    TG 100572 Hydrochloride is a inhibitor of multi-targeted kinase which inhibits receptor tyrosine kinases and Src kinases.

  • (Z)-FeCP-oxindole

    (Z)-FeCP-oxindole is a selective inhibitor of VEGFR2 with an IC50 of 200 nM for humans and demonstrates anticancer activity.

  • Regorafenib hydrochl...

    Regorafenib hydrochloride (BAY73-4506) is a potent, orally active multikinase inhibitor.